Metropolitan Life Insurance Company (MetLife)’s Synovus SNV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-26,528
| Closed | -$1.27M | – | 2636 |
|
|
2021
Q4 | $1.27M | Sell |
26,528
-690
| -3% | -$32.7K | 0.02% | 807 |
|
|
2021
Q3 | $1.19M | Sell |
27,218
-1,363
| -5% | -$57.6K | 0.02% | 829 |
|
|
2021
Q2 | $1.25M | Buy |
28,581
+520
| +2% | +$24.4K | 0.02% | 843 |
|
|
2021
Q1 | $1.28M | Buy |
28,061
+1,588
| +6% | +$66.5K | 0.02% | 780 |
|
|
2020
Q4 | $857K | Sell |
26,473
-627
| -2% | -$18.1K | 0.01% | 987 |
|
|
2020
Q3 | $574K | Sell |
27,100
-1,433
| -5% | -$29.9K | 0.01% | 1114 |
|
|
2020
Q2 | $586K | Sell |
28,533
-10,814
| -27% | -$209K | 0.01% | 1082 |
|
|
2020
Q1 | $691K | Sell |
39,347
-2,142
| -5% | -$66K | 0.01% | 869 |
|
|
2019
Q4 | $1.63M | Sell |
41,489
-1,954
| -4% | -$71.8K | 0.03% | 650 |
|
|
2019
Q3 | $1.55M | Sell |
43,443
-4,021
| -8% | -$144K | 0.03% | 624 |
|
|
2019
Q2 | $1.66M | Sell |
47,464
-500
| -1% | -$17.4K | 0.03% | 610 |
|
|
2019
Q1 | $1.65M | Buy |
47,964
+14,187
| +42% | +$521K | 0.03% | 592 |
|
|
2018
Q4 | $1.08M | Sell |
33,777
-155
| -0.5% | -$5.84K | 0.02% | 766 |
|
|
2018
Q3 | $1.55M | Sell |
33,932
-717
| -2% | -$36.1K | 0.03% | 667 |
|
|
2018
Q2 | $1.83M | Buy |
34,649
+411
| +1% | +$21.9K | 0.03% | 566 |
|
|
2018
Q1 | $1.71M | Buy |
34,238
+25
| +0.1% | +$1.26K | 0.02% | 630 |
|
|
2017
Q4 | $1.64M | Sell |
34,213
-194,377
| -85% | -$9.21M | 0.02% | 657 |
|
|
2017
Q3 | $10.5M | Buy |
228,590
+113,516
| +99% | +$4.92M | 0.07% | 262 |
|
|
2017
Q2 | $5.09M | Buy |
115,074
+1,035
| +0.9% | +$43.5K | 0.04% | 563 |
|
|
2017
Q1 | $4.68M | Sell |
114,039
-293
| -0.3% | -$12.2K | 0.03% | 635 |
|
|
2016
Q4 | $4.7M | Sell |
114,332
-1,016
| -0.9% | -$37.4K | 0.03% | 607 |
|
|
2016
Q3 | $3.75M | Sell |
115,348
-2,508
| -2% | -$78.8K | 0.03% | 697 |
|
|
2016
Q2 | $3.42M | Buy |
117,856
+3,168
| +3% | +$96.2K | 0.03% | 711 |
|
|
2016
Q1 | $3.32M | Sell |
114,688
-404
| -0.4% | -$11.6K | 0.03% | 705 |
|
|
2015
Q4 | $3.73M | Sell |
115,092
-707
| -0.6% | -$22.5K | 0.03% | 631 |
|
|
2015
Q3 | $3.43M | Sell |
115,799
-2,049
| -2% | -$62.8K | 0.02% | 675 |
|
|
2015
Q2 | $3.63M | Sell |
117,848
-2,245
| -2% | -$64.9K | 0.03% | 706 |
|
|
2015
Q1 | $3.36M | Buy |
120,093
+3,789
| +3% | +$103K | 0.02% | 697 |
|
|
2014
Q4 | $3.15M | Sell |
116,304
-996
| -0.8% | -$25.2K | 0.02% | 758 |
|
|
2014
Q3 | $2.77M | Buy |
117,300
+936
| +0.8% | +$22.4K | 0.02% | 800 |
|
|
2014
Q2 | $2.84M | Buy |
116,364
+334
| +0.3% | +$7.79K | 0.02% | 831 |
|
|
2014
Q1 | $2.75M | Buy |
116,030
+2,219
| +2% | +$54K | 0.02% | 820 |
|
|
2013
Q4 | $2.87M | Sell |
113,811
-217
| -0.2% | -$5.11K | 0.02% | 787 |
|
|
2013
Q3 | $2.63M | Buy |
114,028
+22,808
| +25% | +$520K | 0.02% | 788 |
|
|
2013
Q2 | $1.86M | Buy |
+91,220
| New | +$1.73M | 0.01% | 915 |
|
Other funds holding SNV
SF
SAM
Metropolitan Life Insurance Company (MetLife)'s SNV Position: Q1 2022 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Synovus (SNV) in Q1 2022, closing a stake of 26,528 shares — an estimated $1.27M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in SNV in Q2 2013 and held it in 35 quarters. The position peaked at $10.5M in Q3 2017. 439 funds tracked by Wall St. Rank hold SNV as of Q1 2022.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Synovus position as of Q1 2022 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 26,528 Synovus shares in Q1 2022, an estimated $1.27M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Synovus in Q2 2013 and held it in 35 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Synovus position peaked at $10.5M in Q3 2017.
- 439 funds tracked by Wall St. Rank held Synovus as of Q1 2022.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.